0 NASDAQ Companies - June 15, 2019ROADSTER-2 Demonstrates Compelling Patient Outcomes with Strong Safety ProfileRead More
0 NYSE Companies - June 15, 2019Les contrôleurs de la circulation ferroviaire représentés par la CFTC ratifient une nouvelle convention collective du CNRead More
0 NASDAQ Companies - June 15, 2019Editas Medicine Presents Pre-Clinical Data for Treatment of Sickle Cell Disease and Beta-Thalassemia at the 24th Congress of the European Hematology AssociationRead More
0 NASDAQ Companies - June 15, 2019Sunesis Pharmaceuticals Announces Presentation of Preliminary Data from Phase 1b/2 Trial of Vecabrutinib in Patients with CLL and Other B-Cell Malignancies at EHA Annual MeetingRead More
0 NASDAQ Companies - June 15, 2019Apellis Pharmaceuticals Presents Data from Ongoing APL-2 Phase 2 Study in Patients with Cold Agglutinin Disease and Warm Antibody Autoimmune Hemolytic Anemia at 24th European Hematology Association (EHA) CongressRead More
0 NASDAQ Companies - June 15, 2019Forty Seven, Inc. Announces Updated Data from Phase 1b/2 Clinical Trial of 5F9 in Combination with Rituximab in Patients with Relapsed/Refractory Non-Hodgkin’s LymphomaRead More
